SlideShare ist ein Scribd-Unternehmen logo
1 von 25
Prepared by :- PATEL PARTH
                            M.Pharm
                          (QA-Sem II)
S.J. Thakkar Pharmacy College, Rajkot

  Guided by :- Mrs. Jagruti P. Vaghela
               (Assistant Professor) &

                  Mrs. Parula B. Patel
                (Associate Professor)


                                         1
I.    INTRODUCTION :-
  Solid oral dosage forms are designed to deliver the drug through physiological
   mechanisms that preside throughout the gastrointestinal tract.
  Solid oral dosage forms provide a highly reproducible and convenient form of
   drug delivery
  To design an effective delivery system, it is important to know the physical state
   of the API in the dosage form; therefore, this chapter will focus to a large extent
   on the solid-state aspects of the solid oral dosage forms.




                                                                                         2
II.       Physicochemical characterization techniques :-
   Physicochemical characterization techniques are beginning to play a major role
       in the drug development process because they help us to understand the
       mechanism of drug delivery.
      An assessment of the internal structure of the dosage form and the micro
       homogeneity and morphology of the API in the dosage form can be made with
       the techniques that are discussed in this chapter.
      These techniques include,
  A.     Microscopy
  B.     X-ray powder diffraction
  C.     Thermal analysis
  D.     FTIR micro spectroscopy
  E.     NMR imaging
  F.     Mass spectroscopy
  G.     Raman spectroscopy
                                                                                     3
A.     Microscopy :-
  Light microscopy, PLM, SEM, and transmission microscopy are nondestructive
   techniques that can provide insight into the composition and homogeneity of the
   API throughout the dosage form.
  PLM and energy-dispersive X-ray spectroscopy (used in conjunction with SEM)
   are utilized to determine how an API is distributed within a granulation.
  Energy-dispersive X-ray spectroscopy, an elemental analysis technique, used to
   map chlorine content and reveal the distribution of the API in the granulation.
  These experiments demonstrate that the API exists as the hydrochloride salt in
   the granulation and retains its original particle size distribution; therefore, the
   high temperatures and drying conditions used in the manufacturing process do
   not appear to have negatively affected the drug substance.



                                                                                         4
FIGURE 1                                     FIGURE 2
Polarized light micrograph of a granulation. Chlorine mapping of a granulation containing a
 Crystals of the API (see arrow) are visible             hydrochloride salt API.
     within the matrix of the granulation.

                                                                                              5
B. X-Ray Powder Diffraction :-
  The molecules in a crystalline compound are ordered in a three-dimensional
     array called a lattice.
    When a collimated beam of X-rays is incident upon this lattice, X-rays are
     diffracted.
    Every crystal form of a compound produces its own characteristic X-ray
     diffraction pattern.
    This technique is useful for distinguishing between solid-state forms of a bulk
     drug substance and for characterizing changes in the solid state (e.g.,
     distinguishing between polymorphs, hydrates, and solvates and characterizing
     phase transitions between them).
    The technique is also useful for characterizing changes in the drug substance in
     a solid state as it exists in a matrix of a formulation—for example, a change
     from a crystalline to an amorphous form or hydration, dehydration, etc.
                                                                                        6
• To confirm that polymorphic form of the API does not change during the
  manufacturing process, an experiment was done utilizing X-ray powder
  diffraction patterns of crushed tablets, crushed placebo tablets and three lots
  of API were acquired.
                                         FIGURE 3
• X-ray powder diffraction patterns of crushed tablets (pattern 1), crushed placebo tablets
                    (pattern 2), and three lots of the API (patterns 3–5).




                                                                                              7
 As seen in the diffraction patterns, the crystal structure of the API remained
  unchanged during processing. This study revealed no obvious evidence of
  polymorphic changes of the API due to the manufacturing process.

C. Thermal analysis :-
 Simultaneous thermo gravimetric and differential thermal analysis (TG/DTA) is
  a useful technique for the solid-state characterization of pharmaceutical
  materials.
 Such characterization includes the determinations of loss on drying, phase
  transition temperatures, thermal stability, and whether or not water is bound or
  unbound. The TG/DTA data are derived from the response of the sample to a
  heating program.
 TG/DTA was utilized to monitor changes in the crystal morphology and physical
  changes of a hydrated API in a granulation blend and in tablets compressed
  from the blend.
                                                                                     8
D. FT-IR Micro spectroscopy :-
 FTIR micro spectroscopy, equipped with an automated stage, is a nondestructive
  technique that can be utilized to analyze small samples and to chemically map
  locations by identifying components within the sample.
 When unidentified crystalline particles were found growing on tablets during a
  stability study, FTIR micro spectroscopy with a spectral resolution of about 5 μm
  was used to chemically analyze and identify the minute particles.

E.  NMR Spectroscopy :-
I. NMR Imaging :-
 To understand the release of an API from controlled-release tablets containing
  HPMC, NMR imaging techniques were used to measure the relaxation times and
  self-diffusion coefficients (SDCs) of water across the gel layer.
                                                                                      9
 In this study, the SDC values were found to increase with increasing distance
  from the gel region to the core of the tablet.
 The SDC gradients (the change in SDC value over distance) were found to vary
  among HPMC tablets with different levels of polymer substitution.
 This type of in vitro NMR imaging experiment can provide important information
  to guide formulation optimization and aid in the design of drug products that
  deliver the desired in vivo release characteristics.

                FIGURE 4
       Self-diffusion coefficients
      of water across the gel layer
           of an HPMC tablet
        after 3 hours hydration.

                                                                               10
 In another study, NMR imaging with a modified flow-through dissolution
    apparatus was used to assess the swelling of HPMC tablets.
   The series of images reproduced to show the physical changes in HPMC tablets
    over time under static conditions.
   Determining the swelling behavior of the HPMC with this type of imaging may
    increase the understanding of the release of the API from the dosage form.
   This approach was successfully applied to the study of matrix-controlled-
    release tablets as well as osmotic-release tablets.
   NMR imaging techniques provide information about the nature of the physical
    processes involved in the disintegration and dissolution of the drug product.




                                                                                11
FIGURE 5
NMR images of HPMC tablets within a flow-through dissolution apparatus under static
conditions at swelling times of 1, 5, 13, and 19 hours (a–d, respectively). The black center
  regions show where the tablet is dry, and the bright regions around the tablet show
                                  where the gel is swollen.




                                                                                               12
II.  Solid-State NMR :-
 Solid-state NMR studies have been used to study the characteristics of an API in
  melt-extruded pellets.

 The purpose of the study was to determine whether the high temperatures at
      which the melt extrusion process was conducted caused physical changes in the
      drug substance, such as the formation of a different polymorph or a change in
      salt form.




                                                                                  13
F.   Mass Spectrometry :-
 Recently, time-of-flight MS combined with secondary-ion monitoring (TOF-SIMS)
  has been reported to be a useful tool for characterizing and imaging the
  distribution of the components within a solid dosage form.
 A pellet consisting of a ∼100-μm-wide silica core, a ∼100-μm-wide metoprolol
  drug layer, and a ∼50-μm-wide outer coating of ethyl cellulose was cross
  sectioned and bombarded with a 15-keV Ga+ ion source, and the mass spectra
  obtained from the regions of interest provided information about the
  distribution of the various components.
 The resulting image for the metoprolol molecular species reveals the absence of
  drug in the inner and outer layers of the pellet



                                                                                14
FIGURE 6




 This technique :-
 could be extremely important for assessing the controlled release properties of
  a solid oral dosage form.
 The homogeneity and quality of the manufacturing process could be determined.
 applied to the analysis of the surface of beads, tablets, and granulations,
  allowing the chemical composition of more than one layer to be evaluated.


                                                                                15
F. Raman spectroscopy :-

  Laser source Raman spectroscopy is used to analyze solid dispersion to
   evaluate the physical properties and determine the distribution of ibuprofen in
   extrudates of polyvinyl pyrrolidone.
  As shown in figure, a shift in the raman spectra occurs when the crystalline
   form of ibuprofen is compared to a solution or a PVP extrudate containing
   ibuprofen.
  The lack of any raman shifts during a stability study indicates that ibuprofen in
   the melt extrudate is stable and that there were no crystallization processes
   that could affect the dissolution and bioavailability.




                                                                                   16
FIGURE 7
      Raman spectra of three ibuprofen formulations. Ibuprofen formulations: solution
   (dimer 3), solid line; extrudate (PVP), dashed line; crystalline powder, dotted line. The
ibuprofen extrudate and solution are shifted compared to the crystalline form of ibuprofen.




                                                                                               17
III. NEAR INFRARED ANALYSIS :-

   There is intense interest in using NIR techniques in several major areas of
    pharmaceutical operations: clinical supply identification, incoming raw material
    identification, assay and content uniformity testing of finished products.
   The following sections describe qualitative and quantitative examples of
    validated NIR methods currently in use.
  a) Qualitative NIR Analysis :-
  1. Verification of the Identity of Packaged Clinical Supplies :-
   An NIR spectroscopic method to identify pharmaceutically active and inactive
    (placebo) clinical dosage forms is recently developed.
   NIR analysis is particularly suited to the verification of the identity of packaged
    clinical supplies because of its nondestructive nature, speed, and low cost.
   The method was developed to create and validate a one-time-use library of the
    spectra of clinical dosage forms prepared for double-blind clinical trials.
                                                                                      18
FIGURE 8
NIR spectra of known active and placebo (inactive) products packaged into
                             blister cards.




                                                                            19
2. Raw Material Identification :-

  Use of the technique for raw material identification is done for preparing the
   library which is composed of spectra from dozens of lots that are averaged into
   a single spectrum for each raw material.
  The spectrum of an unknown material is matched against all possible similar
   compounds.
  The unknown is either accepted or rejected based upon how close (within
   accepted variations) its spectrum matches that of a known compound.

 3. Blend Homogeneity :-
  NIR spectra obtained after different mixing intervals were used to assess the
    extent to which four components were blended in a V-blender at ―high,‖ ―middle‖
    and ―low‖ positions on the blender at the 1, 5, 15 & 20 minute intervals.
                                                                                  20
 This experiment shows the feasibility of using NIR to determine the blend
  homogeneity of both API and excipients simultaneously in real time, thus
  ensuring optimal content uniformity during compression or capsule filling.
 Spectra of four component blend after 1 minute and 20 minutes of mixing are
  illustrated in figures.
                                         FIGURE 9
   NIR spectra at high, middle, and low positions of a V-blender after 1 minute of mixing.




                                                                                             21
FIGURE 18
NIR spectra at high, middle, and low positions of a V-blender after 20 minutes of
                                     mixing.




                                                                                    22
b) Quantitative NIR Analysis :-
 Once an NIR method is validated, the scanning of the tablets and calculation of
  the results require less than 1 minute.
 Thus, it becomes practical to assay hundreds of finished units from a batch
  throughout a production run instead of selecting a few samples on a small,
  randomized sampling protocol.




                                                                                23
 References :-
 SEPARATION SCIENCE AND TECHNOLOGY A reference series edited by Satinder
  Ahuja volume-III Handbook of modern pharmaceautical analysis by Satinder
  Ahuja and Stephen Scypinski, published by Academic press pg no. 235 to 252.
 www.opticsinfobase.org Article – drug characterization using Raman
  spectroscopy
 www.horiba.com Article – Particle size and shape analysis of API
 Handbook of Thermal analysis and calorimetry volume-5 , recent advances,
  techniques and applications, Editors-Michael E. Brown, Patrick Kent Gallagher




                                                                                  24
25

Weitere ähnliche Inhalte

Was ist angesagt?

Formulation and evaluation of
Formulation and evaluation ofFormulation and evaluation of
Formulation and evaluation of
Gajanan Ingole
 

Was ist angesagt? (20)

OPTIMIZATION TECHNIQUES IN PHARMACEUTICAL FORMULATION AND PROCESSING
OPTIMIZATION TECHNIQUES IN PHARMACEUTICAL FORMULATION AND PROCESSINGOPTIMIZATION TECHNIQUES IN PHARMACEUTICAL FORMULATION AND PROCESSING
OPTIMIZATION TECHNIQUES IN PHARMACEUTICAL FORMULATION AND PROCESSING
 
Seminar on dissolution profile comparison
Seminar on dissolution profile comparisonSeminar on dissolution profile comparison
Seminar on dissolution profile comparison
 
Formulation and evaluation of gastroretentative floating sustained releasedme...
Formulation and evaluation of gastroretentative floating sustained releasedme...Formulation and evaluation of gastroretentative floating sustained releasedme...
Formulation and evaluation of gastroretentative floating sustained releasedme...
 
Pharmaceuticals Dispersion theory- Suspension and Emulsion
Pharmaceuticals Dispersion theory-  Suspension and EmulsionPharmaceuticals Dispersion theory-  Suspension and Emulsion
Pharmaceuticals Dispersion theory- Suspension and Emulsion
 
quality by design in pharmaceutical development ICH Q8 guideliness
quality by design in pharmaceutical development ICH Q8 guidelinessquality by design in pharmaceutical development ICH Q8 guideliness
quality by design in pharmaceutical development ICH Q8 guideliness
 
Clinical significance of bioequivalence and biowaivers
Clinical significance  of bioequivalence and biowaiversClinical significance  of bioequivalence and biowaivers
Clinical significance of bioequivalence and biowaivers
 
Distribution records
Distribution recordsDistribution records
Distribution records
 
Supac
SupacSupac
Supac
 
Product Stability Studies & Stability Testing
Product Stability Studies & Stability Testing Product Stability Studies & Stability Testing
Product Stability Studies & Stability Testing
 
Stability indicating assay
Stability indicating assayStability indicating assay
Stability indicating assay
 
Ich q8 ppt
Ich q8 pptIch q8 ppt
Ich q8 ppt
 
Colon specific drug delivery system
Colon specific drug delivery systemColon specific drug delivery system
Colon specific drug delivery system
 
Formulation and evaluation of
Formulation and evaluation ofFormulation and evaluation of
Formulation and evaluation of
 
disso models ppt
 disso models ppt disso models ppt
disso models ppt
 
Dissolution and drug release testing
Dissolution and drug release testingDissolution and drug release testing
Dissolution and drug release testing
 
Approaches to extend gastro intestine transit
Approaches to extend gastro intestine transitApproaches to extend gastro intestine transit
Approaches to extend gastro intestine transit
 
Ich q8
Ich q8Ich q8
Ich q8
 
Dissolution f1 and f2 Analysis and IVIVC
Dissolution f1 and f2 Analysis and IVIVCDissolution f1 and f2 Analysis and IVIVC
Dissolution f1 and f2 Analysis and IVIVC
 
factors affecting dissolution rate a full view.
 factors affecting dissolution rate a full view. factors affecting dissolution rate a full view.
factors affecting dissolution rate a full view.
 
Pharmaceutical excipients
Pharmaceutical excipients Pharmaceutical excipients
Pharmaceutical excipients
 

Ähnlich wie Analysis of solid oral

Analysis of solid oral dosage forms 112070804010
Analysis of solid oral dosage forms 112070804010Analysis of solid oral dosage forms 112070804010
Analysis of solid oral dosage forms 112070804010
Patel Parth
 
FORMULATION AND EVALUATION OF GELATIN MICROSPHERES LOADED WITH FENOFIBRATE
FORMULATION AND EVALUATION OF GELATIN MICROSPHERES LOADED WITH FENOFIBRATEFORMULATION AND EVALUATION OF GELATIN MICROSPHERES LOADED WITH FENOFIBRATE
FORMULATION AND EVALUATION OF GELATIN MICROSPHERES LOADED WITH FENOFIBRATE
Reshma Fathima .K
 
Formulation and evaluation of gelatin microspheres loaded with fenofibrate
Formulation and evaluation of gelatin microspheres loaded with fenofibrateFormulation and evaluation of gelatin microspheres loaded with fenofibrate
Formulation and evaluation of gelatin microspheres loaded with fenofibrate
Vimal Patel
 
Analytical tech in pre formulation 112070804009
Analytical tech in pre formulation 112070804009Analytical tech in pre formulation 112070804009
Analytical tech in pre formulation 112070804009
Patel Parth
 
DEVELOPMENT & EVALUATION OF MUCOADHESIVE MICROSPHERES OF PIOGLITAZONE MALEATE
DEVELOPMENT & EVALUATION OF MUCOADHESIVE MICROSPHERES OF PIOGLITAZONE MALEATEDEVELOPMENT & EVALUATION OF MUCOADHESIVE MICROSPHERES OF PIOGLITAZONE MALEATE
DEVELOPMENT & EVALUATION OF MUCOADHESIVE MICROSPHERES OF PIOGLITAZONE MALEATE
Ram C Dhakar
 
Sample Final Report_ Extraction of CYP microsomes
Sample Final Report_ Extraction of CYP microsomesSample Final Report_ Extraction of CYP microsomes
Sample Final Report_ Extraction of CYP microsomes
Eric Sudar
 

Ähnlich wie Analysis of solid oral (20)

Analysis of solid oral dosage forms 112070804010
Analysis of solid oral dosage forms 112070804010Analysis of solid oral dosage forms 112070804010
Analysis of solid oral dosage forms 112070804010
 
TO STUDY THE ANALYSIS OF SOLID ORAL DOSAGE FORMS INCLUDING THE DIFFERENT MODE...
TO STUDY THE ANALYSIS OF SOLID ORAL DOSAGE FORMS INCLUDING THE DIFFERENT MODE...TO STUDY THE ANALYSIS OF SOLID ORAL DOSAGE FORMS INCLUDING THE DIFFERENT MODE...
TO STUDY THE ANALYSIS OF SOLID ORAL DOSAGE FORMS INCLUDING THE DIFFERENT MODE...
 
PREFORMULATION.pptx
PREFORMULATION.pptxPREFORMULATION.pptx
PREFORMULATION.pptx
 
Preformulation and physicochemical property of the drug
Preformulation and physicochemical property of the drugPreformulation and physicochemical property of the drug
Preformulation and physicochemical property of the drug
 
FORMULATION AND EVALUATION OF GEL LOADED MICROSPONGES OF DICLOFENAC SODIUM FO...
FORMULATION AND EVALUATION OF GEL LOADED MICROSPONGES OF DICLOFENAC SODIUM FO...FORMULATION AND EVALUATION OF GEL LOADED MICROSPONGES OF DICLOFENAC SODIUM FO...
FORMULATION AND EVALUATION OF GEL LOADED MICROSPONGES OF DICLOFENAC SODIUM FO...
 
FORMULATION AND EVALUATION OF GELATIN MICROSPHERES LOADED WITH FENOFIBRATE
FORMULATION AND EVALUATION OF GELATIN MICROSPHERES LOADED WITH FENOFIBRATEFORMULATION AND EVALUATION OF GELATIN MICROSPHERES LOADED WITH FENOFIBRATE
FORMULATION AND EVALUATION OF GELATIN MICROSPHERES LOADED WITH FENOFIBRATE
 
Formulation and evaluation of gelatin microspheres loaded with fenofibrate
Formulation and evaluation of gelatin microspheres loaded with fenofibrateFormulation and evaluation of gelatin microspheres loaded with fenofibrate
Formulation and evaluation of gelatin microspheres loaded with fenofibrate
 
Preformulation unit i uips (2)
Preformulation unit i uips (2)Preformulation unit i uips (2)
Preformulation unit i uips (2)
 
Analytical tech in pre formulation 112070804009
Analytical tech in pre formulation 112070804009Analytical tech in pre formulation 112070804009
Analytical tech in pre formulation 112070804009
 
GLB NF KIR
GLB NF KIRGLB NF KIR
GLB NF KIR
 
PREFORMULATION.pptx
PREFORMULATION.pptxPREFORMULATION.pptx
PREFORMULATION.pptx
 
Rakesh Chandra Parida ,M.PHARM PROJECT WORK
Rakesh Chandra Parida ,M.PHARM PROJECT WORKRakesh Chandra Parida ,M.PHARM PROJECT WORK
Rakesh Chandra Parida ,M.PHARM PROJECT WORK
 
FORMULATION AND EVALUATION OF CAPECITABINE IN COLON TARGETING
FORMULATION AND EVALUATION OF CAPECITABINE IN COLON TARGETINGFORMULATION AND EVALUATION OF CAPECITABINE IN COLON TARGETING
FORMULATION AND EVALUATION OF CAPECITABINE IN COLON TARGETING
 
Jddr 188
Jddr 188Jddr 188
Jddr 188
 
Development and validation of stability indicating RP-HPLC method for estimat...
Development and validation of stability indicating RP-HPLC method for estimat...Development and validation of stability indicating RP-HPLC method for estimat...
Development and validation of stability indicating RP-HPLC method for estimat...
 
Preformulation
PreformulationPreformulation
Preformulation
 
DEVELOPMENT & EVALUATION OF MUCOADHESIVE MICROSPHERES OF PIOGLITAZONE MALEATE
DEVELOPMENT & EVALUATION OF MUCOADHESIVE MICROSPHERES OF PIOGLITAZONE MALEATEDEVELOPMENT & EVALUATION OF MUCOADHESIVE MICROSPHERES OF PIOGLITAZONE MALEATE
DEVELOPMENT & EVALUATION OF MUCOADHESIVE MICROSPHERES OF PIOGLITAZONE MALEATE
 
Verapamil
VerapamilVerapamil
Verapamil
 
Development and formulation of metoprolol succinate extended release tablets ...
Development and formulation of metoprolol succinate extended release tablets ...Development and formulation of metoprolol succinate extended release tablets ...
Development and formulation of metoprolol succinate extended release tablets ...
 
Sample Final Report_ Extraction of CYP microsomes
Sample Final Report_ Extraction of CYP microsomesSample Final Report_ Extraction of CYP microsomes
Sample Final Report_ Extraction of CYP microsomes
 

Mehr von Patel Parth

Automated analysis by yatin sankharva copy
Automated analysis by yatin sankharva   copyAutomated analysis by yatin sankharva   copy
Automated analysis by yatin sankharva copy
Patel Parth
 
Automated analysis 112070804013
Automated analysis 112070804013Automated analysis 112070804013
Automated analysis 112070804013
Patel Parth
 
Anda registration in us eu
Anda registration in us  euAnda registration in us  eu
Anda registration in us eu
Patel Parth
 
Analysis of parenteral dosage forms bjl final seminar
Analysis of parenteral dosage forms bjl final seminarAnalysis of parenteral dosage forms bjl final seminar
Analysis of parenteral dosage forms bjl final seminar
Patel Parth
 
Analysis of data (pratik)
Analysis of data (pratik)Analysis of data (pratik)
Analysis of data (pratik)
Patel Parth
 
Analysis of cosmetics 112070804018
Analysis of cosmetics 112070804018Analysis of cosmetics 112070804018
Analysis of cosmetics 112070804018
Patel Parth
 
A seminar on applications of various analytical technique
A seminar on applications of various analytical techniqueA seminar on applications of various analytical technique
A seminar on applications of various analytical technique
Patel Parth
 
23117 copy of oral solid dosage forms
23117 copy of oral solid dosage forms23117 copy of oral solid dosage forms
23117 copy of oral solid dosage forms
Patel Parth
 
4016 solid state analysis
4016 solid state analysis4016 solid state analysis
4016 solid state analysis
Patel Parth
 
4003 regulatory aspect_of_bulk,pharmaceutical,biotech
4003 regulatory aspect_of_bulk,pharmaceutical,biotech4003 regulatory aspect_of_bulk,pharmaceutical,biotech
4003 regulatory aspect_of_bulk,pharmaceutical,biotech
Patel Parth
 
A.a sequence analysis 112070804002
A.a sequence analysis 112070804002A.a sequence analysis 112070804002
A.a sequence analysis 112070804002
Patel Parth
 
Sterility testing 112070804014
Sterility testing 112070804014Sterility testing 112070804014
Sterility testing 112070804014
Patel Parth
 
Ria 112070804007
Ria 112070804007Ria 112070804007
Ria 112070804007
Patel Parth
 
Qc lab 112070804001
Qc lab 112070804001Qc lab 112070804001
Qc lab 112070804001
Patel Parth
 
Pyrogen testing 112070804005
Pyrogen testing  112070804005Pyrogen testing  112070804005
Pyrogen testing 112070804005
Patel Parth
 
Pyrogen 112070804004
Pyrogen  112070804004Pyrogen  112070804004
Pyrogen 112070804004
Patel Parth
 
Microbial limit test 112070804013
Microbial limit test  112070804013Microbial limit test  112070804013
Microbial limit test 112070804013
Patel Parth
 

Mehr von Patel Parth (20)

Automated analysis by yatin sankharva copy
Automated analysis by yatin sankharva   copyAutomated analysis by yatin sankharva   copy
Automated analysis by yatin sankharva copy
 
Automated analysis 112070804013
Automated analysis 112070804013Automated analysis 112070804013
Automated analysis 112070804013
 
Anda registration in us eu
Anda registration in us  euAnda registration in us  eu
Anda registration in us eu
 
Anda ppt
Anda pptAnda ppt
Anda ppt
 
Analysis of parenteral dosage forms bjl final seminar
Analysis of parenteral dosage forms bjl final seminarAnalysis of parenteral dosage forms bjl final seminar
Analysis of parenteral dosage forms bjl final seminar
 
Analysis of data (pratik)
Analysis of data (pratik)Analysis of data (pratik)
Analysis of data (pratik)
 
Analysis of cosmetics 112070804018
Analysis of cosmetics 112070804018Analysis of cosmetics 112070804018
Analysis of cosmetics 112070804018
 
Agencies dhwani
Agencies dhwaniAgencies dhwani
Agencies dhwani
 
A seminar on applications of various analytical technique
A seminar on applications of various analytical techniqueA seminar on applications of various analytical technique
A seminar on applications of various analytical technique
 
23117 copy of oral solid dosage forms
23117 copy of oral solid dosage forms23117 copy of oral solid dosage forms
23117 copy of oral solid dosage forms
 
4016 solid state analysis
4016 solid state analysis4016 solid state analysis
4016 solid state analysis
 
4003 regulatory aspect_of_bulk,pharmaceutical,biotech
4003 regulatory aspect_of_bulk,pharmaceutical,biotech4003 regulatory aspect_of_bulk,pharmaceutical,biotech
4003 regulatory aspect_of_bulk,pharmaceutical,biotech
 
A.a sequence analysis 112070804002
A.a sequence analysis 112070804002A.a sequence analysis 112070804002
A.a sequence analysis 112070804002
 
Chi square test
Chi square testChi square test
Chi square test
 
Sterility testing 112070804014
Sterility testing 112070804014Sterility testing 112070804014
Sterility testing 112070804014
 
Ria 112070804007
Ria 112070804007Ria 112070804007
Ria 112070804007
 
Qc lab 112070804001
Qc lab 112070804001Qc lab 112070804001
Qc lab 112070804001
 
Pyrogen testing 112070804005
Pyrogen testing  112070804005Pyrogen testing  112070804005
Pyrogen testing 112070804005
 
Pyrogen 112070804004
Pyrogen  112070804004Pyrogen  112070804004
Pyrogen 112070804004
 
Microbial limit test 112070804013
Microbial limit test  112070804013Microbial limit test  112070804013
Microbial limit test 112070804013
 

Analysis of solid oral

  • 1. Prepared by :- PATEL PARTH M.Pharm (QA-Sem II) S.J. Thakkar Pharmacy College, Rajkot Guided by :- Mrs. Jagruti P. Vaghela (Assistant Professor) & Mrs. Parula B. Patel (Associate Professor) 1
  • 2. I. INTRODUCTION :-  Solid oral dosage forms are designed to deliver the drug through physiological mechanisms that preside throughout the gastrointestinal tract.  Solid oral dosage forms provide a highly reproducible and convenient form of drug delivery  To design an effective delivery system, it is important to know the physical state of the API in the dosage form; therefore, this chapter will focus to a large extent on the solid-state aspects of the solid oral dosage forms. 2
  • 3. II. Physicochemical characterization techniques :-  Physicochemical characterization techniques are beginning to play a major role in the drug development process because they help us to understand the mechanism of drug delivery.  An assessment of the internal structure of the dosage form and the micro homogeneity and morphology of the API in the dosage form can be made with the techniques that are discussed in this chapter.  These techniques include, A. Microscopy B. X-ray powder diffraction C. Thermal analysis D. FTIR micro spectroscopy E. NMR imaging F. Mass spectroscopy G. Raman spectroscopy 3
  • 4. A. Microscopy :-  Light microscopy, PLM, SEM, and transmission microscopy are nondestructive techniques that can provide insight into the composition and homogeneity of the API throughout the dosage form.  PLM and energy-dispersive X-ray spectroscopy (used in conjunction with SEM) are utilized to determine how an API is distributed within a granulation.  Energy-dispersive X-ray spectroscopy, an elemental analysis technique, used to map chlorine content and reveal the distribution of the API in the granulation.  These experiments demonstrate that the API exists as the hydrochloride salt in the granulation and retains its original particle size distribution; therefore, the high temperatures and drying conditions used in the manufacturing process do not appear to have negatively affected the drug substance. 4
  • 5. FIGURE 1 FIGURE 2 Polarized light micrograph of a granulation. Chlorine mapping of a granulation containing a Crystals of the API (see arrow) are visible hydrochloride salt API. within the matrix of the granulation. 5
  • 6. B. X-Ray Powder Diffraction :-  The molecules in a crystalline compound are ordered in a three-dimensional array called a lattice.  When a collimated beam of X-rays is incident upon this lattice, X-rays are diffracted.  Every crystal form of a compound produces its own characteristic X-ray diffraction pattern.  This technique is useful for distinguishing between solid-state forms of a bulk drug substance and for characterizing changes in the solid state (e.g., distinguishing between polymorphs, hydrates, and solvates and characterizing phase transitions between them).  The technique is also useful for characterizing changes in the drug substance in a solid state as it exists in a matrix of a formulation—for example, a change from a crystalline to an amorphous form or hydration, dehydration, etc. 6
  • 7. • To confirm that polymorphic form of the API does not change during the manufacturing process, an experiment was done utilizing X-ray powder diffraction patterns of crushed tablets, crushed placebo tablets and three lots of API were acquired. FIGURE 3 • X-ray powder diffraction patterns of crushed tablets (pattern 1), crushed placebo tablets (pattern 2), and three lots of the API (patterns 3–5). 7
  • 8.  As seen in the diffraction patterns, the crystal structure of the API remained unchanged during processing. This study revealed no obvious evidence of polymorphic changes of the API due to the manufacturing process. C. Thermal analysis :-  Simultaneous thermo gravimetric and differential thermal analysis (TG/DTA) is a useful technique for the solid-state characterization of pharmaceutical materials.  Such characterization includes the determinations of loss on drying, phase transition temperatures, thermal stability, and whether or not water is bound or unbound. The TG/DTA data are derived from the response of the sample to a heating program.  TG/DTA was utilized to monitor changes in the crystal morphology and physical changes of a hydrated API in a granulation blend and in tablets compressed from the blend. 8
  • 9. D. FT-IR Micro spectroscopy :-  FTIR micro spectroscopy, equipped with an automated stage, is a nondestructive technique that can be utilized to analyze small samples and to chemically map locations by identifying components within the sample.  When unidentified crystalline particles were found growing on tablets during a stability study, FTIR micro spectroscopy with a spectral resolution of about 5 μm was used to chemically analyze and identify the minute particles. E. NMR Spectroscopy :- I. NMR Imaging :-  To understand the release of an API from controlled-release tablets containing HPMC, NMR imaging techniques were used to measure the relaxation times and self-diffusion coefficients (SDCs) of water across the gel layer. 9
  • 10.  In this study, the SDC values were found to increase with increasing distance from the gel region to the core of the tablet.  The SDC gradients (the change in SDC value over distance) were found to vary among HPMC tablets with different levels of polymer substitution.  This type of in vitro NMR imaging experiment can provide important information to guide formulation optimization and aid in the design of drug products that deliver the desired in vivo release characteristics. FIGURE 4 Self-diffusion coefficients of water across the gel layer of an HPMC tablet after 3 hours hydration. 10
  • 11.  In another study, NMR imaging with a modified flow-through dissolution apparatus was used to assess the swelling of HPMC tablets.  The series of images reproduced to show the physical changes in HPMC tablets over time under static conditions.  Determining the swelling behavior of the HPMC with this type of imaging may increase the understanding of the release of the API from the dosage form.  This approach was successfully applied to the study of matrix-controlled- release tablets as well as osmotic-release tablets.  NMR imaging techniques provide information about the nature of the physical processes involved in the disintegration and dissolution of the drug product. 11
  • 12. FIGURE 5 NMR images of HPMC tablets within a flow-through dissolution apparatus under static conditions at swelling times of 1, 5, 13, and 19 hours (a–d, respectively). The black center regions show where the tablet is dry, and the bright regions around the tablet show where the gel is swollen. 12
  • 13. II. Solid-State NMR :-  Solid-state NMR studies have been used to study the characteristics of an API in melt-extruded pellets.  The purpose of the study was to determine whether the high temperatures at which the melt extrusion process was conducted caused physical changes in the drug substance, such as the formation of a different polymorph or a change in salt form. 13
  • 14. F. Mass Spectrometry :-  Recently, time-of-flight MS combined with secondary-ion monitoring (TOF-SIMS) has been reported to be a useful tool for characterizing and imaging the distribution of the components within a solid dosage form.  A pellet consisting of a ∼100-μm-wide silica core, a ∼100-μm-wide metoprolol drug layer, and a ∼50-μm-wide outer coating of ethyl cellulose was cross sectioned and bombarded with a 15-keV Ga+ ion source, and the mass spectra obtained from the regions of interest provided information about the distribution of the various components.  The resulting image for the metoprolol molecular species reveals the absence of drug in the inner and outer layers of the pellet 14
  • 15. FIGURE 6  This technique :-  could be extremely important for assessing the controlled release properties of a solid oral dosage form.  The homogeneity and quality of the manufacturing process could be determined.  applied to the analysis of the surface of beads, tablets, and granulations, allowing the chemical composition of more than one layer to be evaluated. 15
  • 16. F. Raman spectroscopy :-  Laser source Raman spectroscopy is used to analyze solid dispersion to evaluate the physical properties and determine the distribution of ibuprofen in extrudates of polyvinyl pyrrolidone.  As shown in figure, a shift in the raman spectra occurs when the crystalline form of ibuprofen is compared to a solution or a PVP extrudate containing ibuprofen.  The lack of any raman shifts during a stability study indicates that ibuprofen in the melt extrudate is stable and that there were no crystallization processes that could affect the dissolution and bioavailability. 16
  • 17. FIGURE 7 Raman spectra of three ibuprofen formulations. Ibuprofen formulations: solution (dimer 3), solid line; extrudate (PVP), dashed line; crystalline powder, dotted line. The ibuprofen extrudate and solution are shifted compared to the crystalline form of ibuprofen. 17
  • 18. III. NEAR INFRARED ANALYSIS :-  There is intense interest in using NIR techniques in several major areas of pharmaceutical operations: clinical supply identification, incoming raw material identification, assay and content uniformity testing of finished products.  The following sections describe qualitative and quantitative examples of validated NIR methods currently in use. a) Qualitative NIR Analysis :- 1. Verification of the Identity of Packaged Clinical Supplies :-  An NIR spectroscopic method to identify pharmaceutically active and inactive (placebo) clinical dosage forms is recently developed.  NIR analysis is particularly suited to the verification of the identity of packaged clinical supplies because of its nondestructive nature, speed, and low cost.  The method was developed to create and validate a one-time-use library of the spectra of clinical dosage forms prepared for double-blind clinical trials. 18
  • 19. FIGURE 8 NIR spectra of known active and placebo (inactive) products packaged into blister cards. 19
  • 20. 2. Raw Material Identification :-  Use of the technique for raw material identification is done for preparing the library which is composed of spectra from dozens of lots that are averaged into a single spectrum for each raw material.  The spectrum of an unknown material is matched against all possible similar compounds.  The unknown is either accepted or rejected based upon how close (within accepted variations) its spectrum matches that of a known compound. 3. Blend Homogeneity :-  NIR spectra obtained after different mixing intervals were used to assess the extent to which four components were blended in a V-blender at ―high,‖ ―middle‖ and ―low‖ positions on the blender at the 1, 5, 15 & 20 minute intervals. 20
  • 21.  This experiment shows the feasibility of using NIR to determine the blend homogeneity of both API and excipients simultaneously in real time, thus ensuring optimal content uniformity during compression or capsule filling.  Spectra of four component blend after 1 minute and 20 minutes of mixing are illustrated in figures. FIGURE 9 NIR spectra at high, middle, and low positions of a V-blender after 1 minute of mixing. 21
  • 22. FIGURE 18 NIR spectra at high, middle, and low positions of a V-blender after 20 minutes of mixing. 22
  • 23. b) Quantitative NIR Analysis :-  Once an NIR method is validated, the scanning of the tablets and calculation of the results require less than 1 minute.  Thus, it becomes practical to assay hundreds of finished units from a batch throughout a production run instead of selecting a few samples on a small, randomized sampling protocol. 23
  • 24.  References :-  SEPARATION SCIENCE AND TECHNOLOGY A reference series edited by Satinder Ahuja volume-III Handbook of modern pharmaceautical analysis by Satinder Ahuja and Stephen Scypinski, published by Academic press pg no. 235 to 252.  www.opticsinfobase.org Article – drug characterization using Raman spectroscopy  www.horiba.com Article – Particle size and shape analysis of API  Handbook of Thermal analysis and calorimetry volume-5 , recent advances, techniques and applications, Editors-Michael E. Brown, Patrick Kent Gallagher 24
  • 25. 25